Tuesday, September 15, 2026

KT Partners with KOSA to Elevate AI Certification Standards in 2026

KT partners with KOSA to enhance AI literacy and improve the AICE certification, aiming to cultivate industry-relevant AI talent.

KOREA’S PREEMPTIVE STRIKE : The $1.3 Billion Spy Ship Built To Kill Kim’s Submarine Threat Before It Even Starts

South Korea's Navy is advancing its AGX-III program to enhance maritime intelligence capabilities against threats like North Korean submarines.

North Korea’s New Car Ownership Law: A Reaction to Rising Private Vehicle Numbers?

North Korea's rise in car ownership is misinterpreted; it's a formalization of existing private vehicle use, not solely due to new laws.

Health

Celltrion Submits U.S. Phase 4 IND for High-Dose 240 mg Zymfentra

Celltrion has submitted a U.S. Phase 4 trial application to support the use of a higher 240 mg dose of Zymfentra, aiming to expand personalized dosing options and strengthen the drug's position in the U.S. market.

Blood Proteins May Offer Clues to Alzheimer’s Antibody Treatment Benefits and Side-Effect Risks

A South Korean study found that blood levels of complement proteins C1q and C3 may help predict amyloid reduction and ARIA risk in patients receiving lecanemab, though larger studies are needed.

Pentrym Confirms Combination Benefits With Existing Cancer Drugs, Targets “False Resistance”

Pentrym is testing whether targeting the tumor microenvironment alongside existing cancer drugs can overcome “false resistance” and improve treatment effectiveness.

YH42946: The Promising HER2 Targeted Oral Treatment Set to Transform Cancer Care in 2026

Yuhan Corporation will reveal early results of its oral HER2-targeted therapy candidate 'YH42946' in clinical trials by year-end.

SK Biopharm Achieves MSCI ESG AAA Rating for 3rd Consecutive Year: What It Means for the Pharma Industry

SK Biopharm has achieved the highest AAA rating in MSCI's ESG evaluation for three consecutive years.
Latest

Best Abstract Award at KCR 2026: Discover the Impact of AI on Chest X-Ray Analysis

AI double reading of chest X-rays by doctors recognized at Korea's largest radiology conference for enhancing diagnostic accuracy.

TXN10128: Breakthrough Oral ENPP1 Inhibitor Shows 44.4% Tumor Reduction in EGFR Mutation Lung Cancer

TXINNO Bioscience's new drug trial shows tumor reduction in 4 out of 9 patients with EGFR-mutated lung cancer who failed prior treatments.

How AI is Revolutionizing Digital Health: Insights from Welt CEO Kang Sung-ji

Exploring ways to quickly uncover unknown factors that lead to patient illness and death, driven by medical curiosity.

ASleep vs. Traditional Methods: The Future of Sleep Apnea Diagnosis and Treatment

ASleep partners with Air Liquide Healthcare to expand its sleep apnea screening and patient management services.

SEERS Joins KRX Healthcare Index: What This Means for AI in Medicine

Wearable AI diagnostics firm Cears has been newly included in the KRX Healthcare Index effective from September 11.

Why Tergase is the Best Biotechnology Product of 2026: A Deep Dive into Its Innovations

Alteogen's Terghaz was awarded Best Biotechnology Product at the 2026 Prigalien Korea Awards for its recombinant human hyaluronidase.

Navigating FDA Challenges: How SK Biopharmaceuticals Plans to Move Forward with Opacalim

SK Biopharm will maintain its development and commercialization plans for epilepsy drug candidate Opacalim despite FDA's partial clinical hold.

Yuhan’s Leclaza Wins Best Pharmaceutical Product at Asia’s First Prix Galien Awards

Yuhan Corporation's lung cancer drug 'Lecanza' wins Best Pharmaceutical Product at the inaugural 'Prix Galien' in Asia.

Unlocking Cancer Treatment: How Lunit and 10x Genomics Are Pioneering New Biomarkers for Precision Medicine

Lunit partners with 10x Genomics to discover biomarkers predicting cancer drug effectiveness in patients.

How Huons Global is Transforming the Middle East Aesthetic Market with Innovative Products

Huons Group targets the Middle East market by consolidating its aesthetic products, including fillers and botulinum toxin.

Wontech Partners With China’s Yestar to Expand Medical Aesthetics Push

Wontech is partnering with Chinese medical aesthetics group Yestar to expand physician training, clinical collaboration and adoption of its NMPA-approved laser devices in China.

Vuno to Discuss AI for Pediatric Patient Safety at Global Symposium

Vuno will bring domestic and international experts together in Seoul to discuss AI-based early warning and rapid response systems for improving pediatric patient safety.

GC Pharma Wins Approval for Phase 2 Trial of COVID-19 mRNA Vaccine

GC Pharma has received approval for a Phase 2 trial of its COVID-19 mRNA vaccine candidate GC4006A and plans to advance toward Phase 3 while expanding the platform into other disease areas.

RF Bio Earns International Occupational Safety Certification, Strengthening Manufacturing Competitiveness

RF Bio has earned ISO 45001 certification as it strengthens workplace safety and manufacturing quality while expanding its medical aesthetics business globally.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.